(1-(Fluoromethyl)cyclopropyl)methanol can be used as adrenoreceptor ADRA2C inhibitors to treat and/or prevent breathing difficulties including sleep- induced breathing difficulties such as central and obstructive sleep apnoea, snoring (primary and obstructive snoring) , dysphagia, peripheral and cardiac vascular disorders including diabetic microangiopathies and disorders of the peripheral and central nervous system including neurodegenerative and neuroinflammatory disorders.